Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Centessa Pharmaceuticals Plc (CNTA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 131,000,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Centessa Pharmaceuticals is a pharmaceutical company that develops and delivers life-altering and life-enhancing medicines to patients. Co.'s product pipeline includes: Lixivaptan, a vasopressin V2 receptor small molecule inhibitor; SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; Imgatuzumab, an anti-EGFR monoclonal antibody for the treatment of cutaneous squamous cell carcinoma and for the treatment of other solid tumors in the context of combination treatment with immunotherapy; and ZF874, a small molecule chemical chaperone folding corrector of the Z variant of alpha-1-antitrypsin for the treatment of alpha-1-antitrypsin deficiency.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 462,585 462,585 462,585
Total Buy Value $0 $5,865,243 $5,865,243 $5,865,243
Total People Bought 0 1 1 1
Total Buy Transactions 0 2 2 2
Total Shares Sold 231,286 467,028 1,172,061 1,614,107
Total Sell Value $4,567,657 $7,621,691 $19,558,568 $26,191,306
Total People Sold 5 5 7 8
Total Sell Transactions 13 26 57 70
End Date 2025-07-20 2025-04-18 2024-10-18 2023-10-19

   
Records found: 281
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hussain Iqbal J General Counsel   •       –      –    2025-10-15 4 AS $22.41 $134,439 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-10-15 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-24 4 AS $24.00 $840,000 D/D (35,000) 121,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-24 4 OE $9.42 $329,700 D/D 35,000 156,503     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-09-16 4 AS $21.33 $174,846 D/D (8,172) 197,394     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-15 4 AS $21.85 $131,101 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-15 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-10 4 AS $22.00 $440,000 D/D (20,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-10 4 OE $5.84 $116,800 D/D 20,000 125,386     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-10 4 AS $22.00 $550,000 D/D (25,000) 121,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-10 4 OE $9.42 $235,500 D/D 25,000 146,503     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-09 4 AS $20.01 $400,102 D/D (20,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-09 4 OE $5.84 $116,800 D/D 20,000 125,386     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-09 4 AS $20.00 $495,840 D/D (24,792) 121,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-09 4 OE $8.01 $198,584 D/D 24,792 146,295     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-09-09 4 AS $20.00 $140,000 D/D (7,000) 205,566     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-09-09 4 OE $8.01 $40,050 D/D 5,000 212,566     -
   Hussain Iqbal J General Counsel   •       –      –    2025-08-15 4 AS $17.23 $103,380 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-08-15 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-08-01 4 D $17.17 $10,250 D/D (597) 207,566     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-07-29 4 AS $15.23 $126,751 D/D (8,322) 208,163     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-07-25 4 AS $15.56 $155,598 D/D (10,000) 122,279     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-07-25 4 OE $3.85 $38,500 D/D 10,000 132,279     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-07-21 4 AS $15.92 $875,600 D/D (55,000) 221,017     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-07-21 4 OE $3.85 $211,750 D/D 55,000 276,017     -
  281 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us